The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.

Antimicrobial Agents and Chemotherapy
Brandon A ByrdWendy W K Mok

Abstract

Bacteria have a repertoire of strategies to overcome antibiotics in clinical use, complicating our ability to treat and cure infectious diseases. In addition to evolving resistance, bacteria within genetically clonal cultures can undergo transient phenotypic changes and tolerate high doses of antibiotics. These cells, termed persisters, exhibit heterogeneous phenotypes; the strategies that a bacterial population deploys to overcome one class of antibiotics can be distinct from those needed to survive treatment with drugs with another mode of action. It was previously reported that fluoroquinolones, which target DNA topoisomerases, retain the capacity to kill nongrowing bacteria that tolerate other classes of antibiotics. Here, we show that in Escherichia coli stationary-phase cultures and colony biofilms, persisters that survive treatment with the anionic fluoroquinolone delafloxacin depend on the AcrAB-TolC efflux pump. In contrast, we did not detect this dependence on AcrAB-TolC in E. coli persisters that survive treatment with three other fluoroquinolone compounds. We found that the loss of AcrAB-TolC activity via genetic mutations or chemical inhibition not only reduces delafloxacin persistence in nongrowing E. coli MG1655 ...Continue Reading

References

Sep 1, 1991·Antimicrobial Agents and Chemotherapy·R H EngC E Cherubin
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·X S Pan, L M Fisher
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·H I Zgurskaya, H Nikaido
Sep 28, 1999·Trends in Microbiology·M N Alekshun, S B Levy
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·K Poole
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Jan 7, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K Poole
May 26, 2005·The Journal of Antimicrobial Chemotherapy·Keith Poole
Aug 29, 2007·Antimicrobial Agents and Chemotherapy·Karl DrlicaXilin Zhao
Feb 12, 2009·FEMS Microbiology Reviews·Orit Gefen, Nathalie Q Balaban
Jun 10, 2010·Annual Review of Microbiology·Kim Lewis
May 13, 2011·Nature·Kyle R AllisonJames J Collins
Sep 23, 2011·Current Opinion in Microbiology·Kyle R AllisonJames J Collins
Aug 10, 2012·The Journal of Antimicrobial Chemotherapy·Joan M RemyJoseph A Devito
Sep 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Errett C HobbsGisela Storz
Mar 29, 2014·PloS One·Stephanie M Amato, Mark P Brynildsen
Nov 19, 2014·Future Microbiology·Jessica M A BlairLaura J V Piddock
Mar 20, 2015·Clinical Microbiology Reviews·Xian-Zhi LiHiroshi Nikaido
Apr 12, 2015·The Journal of Biological Chemistry·Robin R Shields-CutlerJeffrey P Henderson
Aug 11, 2015·Current Biology : CB·Stephanie M Amato, Mark P Brynildsen
Jan 23, 2016·Nature·Eric D Brown, Gerard D Wright
Apr 16, 2016·Nature Reviews. Microbiology·Asher BraunerNathalie Q Balaban
Dec 13, 2016·Pediatrics·Mary Anne JacksonUNKNOWN COMMITTEE ON INFECTIOUS DISEASES
Feb 12, 2017·Science·Irit Levin-ReismanNathalie Q Balaban
Mar 24, 2017·FEMS Microbiology Reviews·Bram Van den BerghJan Michiels
Dec 12, 2017·Molecular Cell·Arnaud GutierrezJames J Collins
Feb 10, 2018·The Journal of Antimicrobial Chemotherapy·Bryan T MogleWesley D Kufel
Mar 10, 2018·Cell·Sylvain MeylanJames J Collins
Apr 2, 2018·Infectious Diseases and Therapy·Sarah C J JorgensenMichael J Rybak
Jun 20, 2018·Proceedings of the National Academy of Sciences of the United States of America·Wendy W K Mok, Mark P Brynildsen

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCR
immunoprecipitation

Software Mentioned

Dela
FlowJo

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

© 2021 Meta ULC. All rights reserved